JP Morgan Maintains Neutral on Surgery Partners, Raises Price Target to $15

Benzinga Newsdesk www.benzinga.com Neutral 49.5%

Neg 0% Neu 49.5% Pos 0%

JP Morgan analyst Benjamin Rossi maintains Surgery Partners (NASDAQ:SGRY) with a Neutral and raises the price target from $14 to $15.